Sharon Grace
Vice President, Public Relations
703.838.0033 ext. 393

November 1, 2017

Boehringer Ingelheim and Eli Lilly and Company Join Forces with AMGA Foundation to Sponsor its Diabetes: Together 2 Goal® Innovator Track

Alexandria, VA -- AMGA Foundation, the philanthropic arm of AMGA, today announced the Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) diabetes alliance’s support of the Diabetes: Together 2 Goal® (T2G) campaign through sponsorship of the Innovator Track, which will assist medical groups and health systems explore non-traditional measures for improving outcomes for people with chronic conditions, specifically Type 2 diabetes. One of the primary goals of the Innovator Track is to provide a forum for interested T2G participants to explore novel care improvement interventions and identify best practices for the management of Type 2 diabetes and its comorbidities, which can then be shared with AMGA members and the broader healthcare community.

“Boehringer Ingelheim and Lilly are proud to support AMGA Foundation and its Innovator Track participants to support the identification and sharing of new strategies and practical approaches to improve outcomes for people with Type 2 diabetes and cardiovascular disease,” said Jean-Michel Boers, president, Human Pharma, Boehringer Ingelheim Pharmaceuticals, Inc. “We are excited to help sponsor the development of the Together 2 Goal Innovator Track, which we hope will encourage the assessment and implementation of novel, evidence-based care approaches to help people with Type 2 diabetes.”

In March 2016, AMGA Foundation launched Together 2 Goal®, a three-year national campaign to address the challenge of Type 2 diabetes, with a goal of improving care for 1 million people with Type 2 diabetes by 2019. T2G offers a Basic Track and a Core Track for its members to explore and report on standard Type 2 diabetes measures which includes A1C, blood pressure, lipid management, medical attention for nephropathy and bundle measures.  The Innovator Track will explore additional non-traditional measures to improve patient outcomes.

Approximately 30 million Americans and an estimated 415 million people worldwide have diabetes.   Due to the complications associated with diabetes, such as high blood sugar, high blood pressure, and obesity, cardiovascular disease is the leading cause of death associated with diabetes. People with diabetes are two to four times more likely to develop cardiovascular disease than people without diabetes. In the U.S., healthcare costs for managing cardiovascular conditions in patients with diabetes totaled more than $23 billion in 2012.

“We are thrilled to have Boehringer Ingelheim and Lilly involved in the T2G Campaign via the Innovator Track,” said Jerry Penso, M.D., M.B.A., president of AMGA Foundation and chief medical and quality officer at AMGA. “Their support will assist our members in developing innovative care management strategies to improve the lives of people with Type 2 diabetes.”

About the Together 2 Goal® Campaign
AMGA Foundation, the philanthropic arm of AMGA, launched Together 2 Goal®, a three-year national campaign to fight the challenge of Type 2 diabetes on March 12, 2016. Together 2 Goal® includes more than 150 medical groups, health systems, non-profit partners, and corporate collaborators such as the American Diabetes Association, American Association of Diabetes Educators, Novo Nordisk, Inc., Geisinger Health System, Henry Ford Health System, Intermountain Healthcare, and Ochsner Health System. The goal of the three-year campaign is to improve care for 1 million people with Type 2 diabetes by 2019.

About AMGA Foundation
AMGA Foundation is AMGA’s philanthropic arm that enables medical groups and other organized systems of care to consistently improve health and health care. AMGA Foundation serves as a catalyst, connector, and collaborator for translating the evidence of what works best in improving health and health care in everyday practice.

About AMGA
AMGA is a trade association leading the transformation of health care in America. Representing multispecialty medical groups and integrated systems of care, we advocate, educate, innovate, and empower our members to deliver the next level of high performance health. AMGA is the national voice promoting awareness of our members’ recognized excellence in the delivery of coordinated, high-quality, high-value care. More than 175,000 physicians practice in our member organizations, delivering care to one in three Americans. For more information, visit